{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:21:42Z","timestamp":1790043702026,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bcmd.2013.11.001","type":"journal-article","created":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T22:17:50Z","timestamp":1385158670000},"page":"205-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Acquired von Willebrand syndrome in patients with Gaucher disease"],"prefix":"10.1016","volume":"52","author":[{"given":"Mirjana","family":"Mitrovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Elezovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Predrag","family":"Miljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Suvajdzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2013.11.001_bb0005","series-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","first-page":"171","volume":"14","author":"Nicholas","year":"2008"},{"issue":"25","key":"10.1016\/j.bcmd.2013.11.001_bb0010","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.11.001_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1365-2141.1997.d01-2076.x","article-title":"Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy","volume":"96","author":"Hollak","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2013.11.001_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/09537104.2011.597526","article-title":"Haemostatic abnormalities in treatment-na\u00efve patients with Type 1 Gaucher's disease","volume":"2","author":"Mitrovic","year":"2012","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.bcmd.2013.11.001_bb0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bcmd.2012.03.003","article-title":"Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: effects of enzyme replacement therapy","volume":"49","author":"Mitrovic","year":"2012","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.11.001_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1096-8652(199603)51:3<234::AID-AJH9>3.0.CO;2-Y","article-title":"Coagulation abnormalities in patients with Gaucher's disease: effect of therapy","volume":"51","author":"Billett","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2013.11.001_bb0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2141.2011.08613.x","article-title":"Platelet adhesion defect in type I Gaucher disease is associated with a risk of mucosal bleeding","volume":"153","author":"Spectre","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2013.11.001_bb0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1160\/TH10-07-0503","article-title":"Impaired platelet function and peripartum bleeding in women with Gaucher disease","volume":"105","author":"Simchen","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2013.11.001_bb0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2013.11.001_bb0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/08880010701360619","article-title":"Acquired von Willebrand disease in Turkish boy with Gaucher disease","volume":"24","author":"Tavil","year":"2007","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.bcmd.2013.11.001_bb0055","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2141.2007.06701.x","article-title":"Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease","volume":"138","author":"Hughes","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2013.11.001_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10245330500067181","article-title":"Survey of hematological aspects of Gaucher disease","volume":"10","author":"Zimran","year":"2005","journal-title":"Hematology"},{"issue":"8","key":"10.1016\/j.bcmd.2013.11.001_bb0065","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3324\/haematol.12379","article-title":"A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease","volume":"93","author":"Di Rocco","year":"2008","journal-title":"Haematologica"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613002386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613002386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:47Z","timestamp":1761049787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979613002386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1079979613002386"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.11.001","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired von Willebrand syndrome in patients with Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}